Convergence CT solves the Real World Evidence patient data access dilemma for life sciences companies seeking data from Asia. Rich data emerges from diagnoses to treatment, lab tests, imaging, and outcomes that is essential to validate a drug, device, or treatment's efficacy.
Convergence CT has pioneered a rigorous process in how we assist pharma and life sciences companies to secure the desired therapeutic patient group, while working within the strict regulatory environments that prevent doctors from sharing their patient registries.
We design, research, and secure the patient populations safely, securely, and legally; then use advanced analytics within our proprietary sandbox to extract insights, provide reporting, and publish studies in leading journals on behalf of our clients along with our wide hospital and physician network.
